Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.210
-0.110 (-8.33%)
At close: May 30, 2025, 4:00 PM
1.220
+0.010 (0.83%)
After-hours: May 30, 2025, 7:51 PM EDT
Fate Therapeutics Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Fate Therapeutics stock ranges from a low of $2.00 to a high of $6.00. The average analyst price target of $4.14 forecasts a 242.15% increase in the stock price over the next year.
Price Target: $4.14 (+242.15%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Fate Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Buy | 2 | 2 | 2 | 1 | 1 | 2 |
| Hold | 6 | 6 | 6 | 6 | 6 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $10 → $2 | Buy | Maintains | $10 → $2 | +65.29% | May 14, 2025 |
| Baird | Baird | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +230.58% | May 14, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2025 |
| Stifel | Stifel | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +147.93% | Mar 6, 2025 |
| Wedbush | Wedbush | Hold Reiterates $5 | Hold | Reiterates | $5 | +313.22% | Mar 6, 2025 |
Financial Forecast
Revenue This Year
4.96M
from 13.63M
Decreased by -63.63%
Revenue Next Year
3.50M
from 4.96M
Decreased by -29.39%
EPS This Year
-1.45
from -1.64
EPS Next Year
-1.31
from -1.45
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.3M | 14.3M | 14.3M | ||
| Avg | 5.0M | 3.5M | 3.8M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.0% | 188.0% | 307.9% | ||
| Avg | -63.6% | -29.4% | 7.9% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.20 | -0.77 | -0.55 | ||
| Avg | -1.45 | -1.31 | -1.21 | ||
| Low | -1.76 | -1.96 | -2.16 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.